SEC Form 4 · accession 0001209191-15-066874
AGIOS PHARMACEUTICALS, INC. · AGIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lewis Clayton Cantley Jr.
Director
Period of report
Aug 17, 2015
Accepted (ET)
Aug 19, 2015 · 4:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001439222
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF2 | Aug 17, 2015 | S | 2,426 | $94.21 | D | 155,132 | D | |
| Common stockF3,F4 | Aug 17, 2015 | S | 2,426 | $94.18 | D | 155,132 | I | See footnote |
| Common stockF5 | Aug 18, 2015 | S | 2,426 | $95.69 | D | 152,706 | D | |
| Common stockF6,F4 | Aug 18, 2015 | S | 2,426 | $95.69 | D | 152,706 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F2The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $92.46 to $96.24. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F3The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $92.44 to $96.27. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F4Shares held by Vicki Lee Sato, who is the reporting person's spouse.
- F5The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $95.18 to $96.80. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F6The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $95.15 to $96.80. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.